TRPV1 and cancer: Hence, it acts as a TRPV1 agonist by either capsaicin or proton activation, leading to calcium influx and channel desensitization, as well as the defunctionalization of the pain fibres, with consequent analgesic effects in several painful conditions, namely diabetic neuropathy, chronic phantom pain, and cancer pain.